Congenica is a UK start-up company founded on pioneering research from the Wellcome Trust Sanger Institute, NHS clinicians and genetic testing laboratories. We are translating this research into a revolutionary clinical genomic analytics platform, Sapientia, for processing genome-wide data sets of human DNA sequence with deep clinical phenotype information in order to provide a definitive molecular diagnosis and clinically actionable interpretation for treatment, patient stratification and improved therapeutic discoveries.
|Employees (est.) (Jan 2021)||88|
Congenica total Funding
Congenica latest funding size
Time since last funding
|3 months ago|
|Amadeus Capital Partners, Tencent Holdings, Parkwalk Advisors Ltd, Legal & General, Cambridge Innovation Capital, IDO Investments, Future Planet Capital, Puhua Capital, Parkwalk Advisors, Digital China Health Technologies Corporation (DCHealth), Xeraya|
Congenica has 1.9k Twitter Followers. The number of followers has increased 0.3% month over month and increased 1.6% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Congenica founded?
Congenica was founded in 2014.
Who are Congenica key executives?
Congenica's key executives are David Atkins, Nick Lench and Andy Richards.
How many employees does Congenica have?
Congenica has 88 employees.
Who are Congenica competitors?
Competitors of Congenica include Americord, Gemini Therapeutics and Mission Bio.
Where is Congenica headquarters?
Congenica headquarters is located at Wellcome Trust Genome Campus, Hinxton.
Where are Congenica offices?
Congenica has an office in Hinxton.
How many offices does Congenica have?
Congenica has 1 office.
Receive alerts for 300+ data fields across thousands of companies